Metraipolis › archive › dc_6138545f2420
Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A — Europe PMC PMID:42254461
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42254461
- DOI
- 10.1016/j.rpth.2026.106627
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T09:55:41.863Z
- SHA-256 of the archived text
96d38415f53b925173c0b7c1ad9f6894ccae3cf6e1e7b9e8a825444027b81202- Stable URL of this page
https://metraipolis.com/documento/dc_6138545f2420
How to cite
Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A — Europe PMC PMID:42254461 — Europe PMC (en), https://europepmc.org/article/MED/42254461 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6138545f2420 (Metraipolis archive dc_6138545f2420, sha256 96d38415f53b925173c0b7c1ad9f6894ccae3cf6e1e7b9e8a825444027b81202)
BibTeX
@misc{dc6138545f2420,
title = {Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A — Europe PMC PMID:42254461},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42254461},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6138545f2420; sha256 96d38415f53b925173c0b7c1ad9f6894ccae3cf6e1e7b9e8a825444027b81202},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42254461. Agents can read the archived copy with the MCP tool read_document.